These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35551176)

  • 1. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.
    Catalan A; Radua J; McCutcheon R; Aymerich C; Pedruzo B; González-Torres MÁ; Baldwin H; Stone WS; Giuliano AJ; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2022 May; 12(1):198. PubMed ID: 35551176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies.
    Catalan A; McCutcheon RA; Aymerich C; Pedruzo B; Radua J; Rodríguez V; Salazar de Pablo G; Pacho M; Pérez JL; Solmi M; McGuire P; Giuliano AJ; Stone WS; Murray RM; Gonzalez-Torres MA; Fusar-Poli P
    Transl Psychiatry; 2024 Jan; 14(1):15. PubMed ID: 38191534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.
    Pedruzo B; Aymerich C; Pacho M; Herrero J; Laborda M; Bordenave M; Giuliano AJ; McCutcheon RA; Gutiérrez-Rojas L; McGuire P; Stone WS; Fusar-Poli P; González-Torres MÁ; Catalan A
    Eur Child Adolesc Psychiatry; 2024 Oct; 33(10):3377-3387. PubMed ID: 37199754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
    Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis.
    De Micheli A; Provenzani U; Solmi M; Van Pabst AVL; Youssef E; McGuire P; Fusar-Poli P
    Schizophr Res; 2023 Apr; 254():109-115. PubMed ID: 36827942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.
    Aymerich C; Pedruzo B; Pacho M; Laborda M; Herrero J; Pillinger T; McCutcheon RA; Alonso-Alconada D; Bordenave M; Martínez-Querol M; Arnaiz A; Labad J; Fusar-Poli P; González-Torres MÁ; Catalan A
    Psychoneuroendocrinology; 2023 Apr; 150():106049. PubMed ID: 36758330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
    Solmi M; Soardo L; Kaur S; Azis M; Cabras A; Censori M; Fausti L; Besana F; Salazar de Pablo G; Fusar-Poli P
    Mol Psychiatry; 2023 Jun; 28(6):2291-2300. PubMed ID: 37296309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence.
    Woodberry KA; Seidman LJ; Giuliano AJ; Verdi MB; Cook WL; McFarlane WR
    Schizophr Res; 2010 Nov; 123(2-3):188-98. PubMed ID: 20692125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of mild cognitive deficits in risk assessment in early psychosis.
    Zhang T; Cui H; Tang X; Xu L; Wei Y; Hu Y; Tang Y; Wang Z; Liu H; Chen T; Li C; Wang J
    Psychol Med; 2024 Jul; 54(9):2230-2241. PubMed ID: 38433595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.